Tag Archives: Hotchkiss Brain Institute: University of Calgary

Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)

Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Two “Behind the Headlines” Appraisals (NHS Choices / Lancet Neurology / BMJ Open)

Summary The NHS Choices “Behind the Headlines” service produces regular critical appraisals of recent research about elderly care and dementia-related topics which have appeared in the news. Here are two of these: New Drug NA-1 Could Reduce Stroke Risk of … Continue reading

Posted in For Doctors (mostly), For Researchers (mostly), In the News, International, NHS Digital (Previously NHS Choices), Quick Insights, Stroke, Universal Interest | Tagged , , , , , , , , , , , , , , , , , | Leave a comment